InChI | InChI=1S/C80H113ClN18O13.2C2H4O2/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54;2*1-2(3)4/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89);2*1H3,(H,3,4)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+;;/m1../s1 |
Reference | 1.<span style=”font-family: Arial, sans-serif; font-size: 13px;”>Jiang, Guangcheng, et al. "GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6." </span><i style=”font-family: Arial, sans-serif; font-size: 13px;”>Journal of medicinal chemistry</i><span style=”font-family: Arial, sans-serif; font-size: 13px;”> 44.3 (2001): 453-467.<br />
2.</span><span style=”font-family: Arial, sans-serif; font-size: 13px;”>Broqua, Pierre, et al. "Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix." </span><i style=”font-family: Arial, sans-serif; font-size: 13px;”>Journal of Pharmacology and Experimental Therapeutics</i><span style=”font-family: Arial, sans-serif; font-size: 13px;”> 301.1 (2002): 95-102.<br />
3.</span><span style=”font-family: Arial, sans-serif; font-size: 13px;”>Lebovic, Dan I., et al. "PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo-and drug-controlled study." </span><i style=”font-family: Arial, sans-serif; font-size: 13px;”>Fertility and sterility</i><span style=”font-family: Arial, sans-serif; font-size: 13px;”> 88.4 (2007): 1108-1119.</span>
|